ResMed Inc. (RMD)
222.15
-1.70 (-0.76%)
At close: Apr 01, 2025, 3:59 PM
224.62
1.11%
After-hours: Apr 01, 2025, 08:00 PM EDT
ResMed Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 |
Cash & Equivalents | 238.36M | 227.89M | 273.71M | 295.28M | 463.16M |
Short-Term Investments | n/a | 12.42M | 9.17M | n/a | n/a |
Long-Term Investments | 169.77M | -132.97M | -251.49M | -240.82M | -189.74M |
Other Long-Term Assets | 114.23M | 395.43M | 251.49M | 240.82M | 189.74M |
Receivables | 837.27M | 704.91M | 575.95M | 614.29M | 484.1M |
Inventory | 822.25M | 998.01M | 743.91M | 457.03M | 416.92M |
Other Current Assets | 180.01M | 179.93M | 131.26M | n/a | 93.48M |
Total Current Assets | 2.36B | 2.37B | 1.93B | 1.57B | 1.52B |
Property-Plant & Equipment | 699.15M | 665.81M | 630.5M | 592.07M | 535.68M |
Goodwill & Intangibles | 3.33B | 3.32B | 2.28B | 2.32B | 2.34B |
Total Long-Term Assets | 4.51B | 4.38B | 3.16B | 3.15B | 3.06B |
Total Assets | 6.87B | 6.75B | 5.1B | 4.73B | 4.59B |
Account Payables | 237.73M | 150.76M | 159.25M | 138.01M | 135.79M |
Deferred Revenue | 152.55M | 138.07M | 108.67M | 109.61M | 98.62M |
Short-Term Debt | 35.18M | 31.82M | 31.77M | 12M | 11.99M |
Other Current Liabilities | 236.06M | 195.18M | 173.02M | 857.29M | 373.45M |
Total Current Liabilities | 910.65M | 758.53M | 689.3M | 911.77M | 602.76M |
Long-Term Debt | 697.31M | 1.43B | 765.33M | 643.35M | 1.16B |
Other Long-Term Liabilities | 42.26M | 105.35M | 54.86M | 69.73M | 121.26M |
Total Long-Term Liabilities | 1.1B | 1.86B | 1.05B | 930.68M | 1.49B |
Total Liabilities | 2.01B | 2.62B | 1.74B | 1.84B | 2.09B |
Total Debt | 873.93M | 1.58B | 917.55M | 793.72M | 1.3B |
Common Stock | 588K | 588K | 586K | 583K | 580K |
Retained Earnings | 4.99B | 4.25B | 3.61B | 3.08B | 2.83B |
Comprehensive Income | -251.53M | -272.53M | -312.75M | -193.49M | -283.98M |
Shareholders Equity | 4.86B | 4.13B | 3.36B | 2.89B | 2.5B |
Total Investments | 169.77M | -132.97M | -251.49M | -240.82M | -189.74M |